Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9951–10000 of 35188
As of the Effective Time, Mitchell H. Gold, Robert Conway, Min Cui, Natasha Hernday, Christopher Peetz, Peter Thompson, James N. Topper and Jörn Drappa each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
The director of Merger Sub immediately prior to the Effective Time was Charles Wagner.
As of the Effective Time, Mitchell H. Gold, Robert Conway, Min Cui, Natasha Hernday, Christopher Peetz, Peter Thompson, James N. Topper and Jörn Drappa each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
As of the Effective Time, Mitchell H. Gold, Robert Conway, Min Cui, Natasha Hernday, Christopher Peetz, Peter Thompson, James N. Topper and Jörn Drappa each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
As of the Effective Time, Mitchell H. Gold, Robert Conway, Min Cui, Natasha Hernday, Christopher Peetz, Peter Thompson, James N. Topper and Jörn Drappa each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
As of the Effective Time, Mitchell H. Gold, Robert Conway, Min Cui, Natasha Hernday, Christopher Peetz, Peter Thompson, James N. Topper and Jörn Drappa each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
As of the Effective Time, Mitchell H. Gold, Robert Conway, Min Cui, Natasha Hernday, Christopher Peetz, Peter Thompson, James N. Topper and Jörn Drappa each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
As of the Effective Time, Mitchell H. Gold, Robert Conway, Min Cui, Natasha Hernday, Christopher Peetz, Peter Thompson, James N. Topper and Jörn Drappa each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
As of the Effective Time, Mitchell H. Gold, Robert Conway, Min Cui, Natasha Hernday, Christopher Peetz, Peter Thompson, James N. Topper and Jörn Drappa each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
effective May 15, 2024, director Donald L. Nickles retired from the Board in accordance with the terms of Valero Energy Corporation’s (“Valero”) director retirement policy.
On May 17, 2024, Amy B. Schwetz, a member of the Board of Directors (the “Board”) of Dril-Quip, Inc. (“Dril-Quip”) and chair of the Audit Committee thereof, notified Dril-Quip of her intention to resign, effective immediately, from the Board.
On May 17, 2024 (the “Effective Date”), Leonard Sokolow notified the Board of Directors (the “Board”) of the Company that he will resign as a member of the Board and its committees, effective as of the Effective Date
On May 15, 2024, Mohammed Javade Chaudhri, a Class I director of Altenrus Clean Energy, Inc. (the “Company”), notified the Company that they will resign from the Company’s Board of Directors (the “Board”) effective immediately.
On May 20, 2024, the board of directors (the “Board”) of Contineum Therapeutics, Inc. (the “Company”) appointed Troy Ignelzi as a member of its Board, effective immediately.
On May 14, 2024, A. Alexander Taylor, II resigned from service on the Delta Apparel, Inc. Board of Directors (“Board”) and all subcommittees of the Board effective May 14, 2024.
On May 17, 2024, Patrick Kolek provided notice to the Board of Directors (the “Board”) of Skillsoft Corp. (the “Company”) of his decision not to stand for re-election to the Board.
SouthState entered into a transition agreement with Mr. David Brooks setting forth the terms of his service as a member of the board of directors of SouthState for a period from the effective time of the Merger until the date of SouthState’s annual meeting of shareholders expected to be held in April 2027
On May 20, 2024, Jodi Hanson Bond and James Fagan notified AFC Gamma, Inc. (the “Company”) of their respective decisions to resign as directors of the Company, effective upon the completion of the Company’s spin-off of its separate commercial real estate portfolio into an independent, publicly-traded REIT, Sunrise Realty Trust, Inc. (“SUNS”).
On May 20, 2024, Jodi Hanson Bond and James Fagan notified AFC Gamma, Inc. (the “Company”) of their respective decisions to resign as directors of the Company, effective upon the completion of the Company’s spin-off of its separate commercial real estate portfolio into an independent, publicly-traded REIT, Sunrise Realty Trust, Inc. (“SUNS”).
the Board of Directors (the “Board”) of the Company had elected Coretha M. Rushing and David D. Guilmette to the Board, effective as of May 5, 2024.
the Board of Directors (the “Board”) of the Company had elected Coretha M. Rushing and David D. Guilmette to the Board, effective as of May 5, 2024.
On May 15, 2024, Sandford D. Smith notified Cytokinetics, Incorporated (the “Company”) of his resignation from the Board of Directors of the Company (the “Board of Directors”), with such resignation effective immediately before the 2024 annual meeting of stockholders of the Company held on May 15, 2024 (the “Annual Meeting”).
On May 15, 2024, Jon Sebastiani notified the Executive Chairman of the Board of Directors (the “Board”) of Vintage Wine Estates, Inc. (the “Company”) of his decision to resign from his positions as a member of the Board and a member of the Board’s Nominating and Corporate Governance Committee, effective immediately.
On May 13, 2024, the board of directors of Alchemy Investments Acquisition Corp 1 (the “ Company ”) appointed Jinalkumar Bipin Shah as a new director of the Company, effective immediately.
On May 13, 2024, the Board increased the size of the Board by one and appointed William P. Hankowsky as a new director, effective as of the same date.
On May 15, 2024, the Board of directors of the Company appointed Sergei Glinka as a director of the Company.
On May 16, 2024, Cynthia M. Johnson resigned from the Board of Directors (the “Board”) of PROS Holdings, Inc. (the “Company”), effective immediately.
As previously announced on March 25, 2024, after almost 17 years of service on the Board of Directors (the “Board”) of the Company, including 13 years of service as Non-Executive Chairman of the Board and one year as Lead Independent Director, Mr. Richard Daerr, Jr. retired from the Board effective at the conclusion of the Annual Meeting.
Dr. James Kao, who has served as Chair of the Boards for the past three years, will remain on the Board of Directors of the Company and the Bank.
Effective as of the Retirement Date, Mr. McCormick will also retire from the Company’s Board of Directors (the “ Board ”).
On May 14, 2024, Neil Kline notified the board of directors (the "Board") of the Company of his resignation from the Board, effective immediately.
On May 16, 2024, the Board of Directors (“Board”) of GE Vernova Inc. (“Company”) increased its size to nine members and elected Martina Hund-Mejean as a director of the Company, effective immediately, to fill the newly created vacancy.
On May 16, 2024, CSG Systems International, Inc. (“CSG”) announced that it had appointed Samantha Greenberg as a new member of CSG’s Board of Directors (the “Board”), effective May 13, 2024.
On May 10, 2024, the Board of Directors (the “Board”) of Texas Capital Bancshares, Inc. (the “Company”) elected Mark Midkiff as a member of the Board, effective June 1, 2024.
On May 13, 2024, the Board of Directors (the “Board”) of Tennant Company (the “Company”) elected Mark W. Sheahan as a member of the Board effective May 15, 2024.
On May 16, 2024, the Board of Directors (the “Board”) of ArriVent BioPharma, Inc. (the “Company”) appointed John Hohneker, M.D., to the Board, effective as of May 16, 2024 (the “Effective Date”).
On May 16, 2024, Major General Garry C. Dean joined the Board of Directors (the “ Board ”) of Innovative Solutions and Support, Inc. (the “ Company ”) as an independent director for a term until the Company’s next annual meeting of shareholders or until his successor is duly elected and qualified or until his earlier death, disqualification, resignation or removal.
at the Effective Time, Terence Gallagher and Robert McNerney (the “Resigning Directors”) resigned as members of the Board.
at the Effective Time, Terence Gallagher and Robert McNerney (the “Resigning Directors”) resigned as members of the Board.
the following individuals, each of whom was a member of the board of directors of Lakeland immediately prior to consummation of the Merger, were appointed to the board of directors of Provident: Thomas J. Shara, Brian M. Flynn, Brian Gragnolati, James E. Hanson II and Robert E. McCracken.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Lakeland’s directors and executive officers ceased serving as directors and executive officers of Lakeland.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Lakeland’s directors and executive officers ceased serving as directors and executive officers of Lakeland.
the following individuals, each of whom was a member of the board of directors of Lakeland immediately prior to consummation of the Merger, were appointed to the board of directors of Provident: Thomas J. Shara, Brian M. Flynn, Brian Gragnolati, James E. Hanson II and Robert E. McCracken.
the following individuals, each of whom was a member of the board of directors of Lakeland immediately prior to consummation of the Merger, were appointed to the board of directors of Provident: Thomas J. Shara, Brian M. Flynn, Brian Gragnolati, James E. Hanson II and Robert E. McCracken.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Lakeland’s directors and executive officers ceased serving as directors and executive officers of Lakeland.
the following individuals, each of whom was a member of the board of directors of Lakeland immediately prior to consummation of the Merger, were appointed to the board of directors of Provident: Thomas J. Shara, Brian M. Flynn, Brian Gragnolati, James E. Hanson II and Robert E. McCracken.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Lakeland’s directors and executive officers ceased serving as directors and executive officers of Lakeland.
the following individuals, each of whom was a member of the board of directors of Lakeland immediately prior to consummation of the Merger, were appointed to the board of directors of Provident: Thomas J. Shara, Brian M. Flynn, Brian Gragnolati, James E. Hanson II and Robert E. McCracken.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Lakeland’s directors and executive officers ceased serving as directors and executive officers of Lakeland.
In accordance with the terms of the Merger Agreement, at the Effective Time, the directors of Merger Sub, Alexander Israel and Travis Kell, became directors of the Company (collectively, the “ New Directors ”).
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.